What does APOTHEEK JANSSEN do?

APOTHEEK JANSSEN is a pharmacy in Deinze. Public Limited, started on 31 December 1983, 1 establishment.

What is the address of APOTHEEK JANSSEN?

The registered office of APOTHEEK JANSSEN is located at Velostraat 48, 9800 Deinze.

Is APOTHEEK JANSSEN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK JANSSEN is active, legal situation “Normale toestand”, started on 31 December 1983.

Is APOTHEEK JANSSEN registered on Peppol?

Yes, APOTHEEK JANSSEN is registered on the Peppol network with ID 0208:0425202369.

What is the enterprise number of APOTHEEK JANSSEN?

The enterprise number of APOTHEEK JANSSEN is BE0425202369.

When was APOTHEEK JANSSEN founded?

APOTHEEK JANSSEN was founded on 31 December 1983.

Who are the directors of APOTHEEK JANSSEN?

According to the 2025 annual accounts, the directors of APOTHEEK JANSSEN are: Leen De Coninck, ARCOFAR.

Is APOTHEEK JANSSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 December 1983; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK JANSSEN make in 2025?

APOTHEEK JANSSEN posted a profit after taxes of € 67,165 in financial year 2025.

What is the revenue of APOTHEEK JANSSEN?

As a small company, APOTHEEK JANSSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 215,257.

How much does an employee at APOTHEEK JANSSEN earn?

The average wage cost per full-time employee at APOTHEEK JANSSEN was € 95,000 in 2025: staff costs of € 123,458 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK JANSSEN have?

According to the 2025 annual accounts, APOTHEEK JANSSEN has 1.3 full-time equivalents (FTE).

Does APOTHEEK JANSSEN have a website?

Yes, APOTHEEK JANSSEN has a website at apotheekdeinze.be.

APOTHEEK JANSSEN (Public Limited) - Deinze - BE0425202369

Dossier APOTHEEK JANSSEN, printed on 30 October 2026 from databakkes.be/en/0425202369/apotheek-janssen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK JANSSEN from Deinze, company number BE0425202369, closed financial year 2025 with a result of € 67,165 after tax. For that financial year APOTHEEK JANSSEN recorded a gross margin of € 215,257 and equity of € 68,200. Compared with financial year 2024, the result moved from € 58,959 to € 67,165. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What it is worth Healthy

€ 68,200

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 67,165

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 388,751

▲ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 73,158 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

1.3

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 123,458

▲ 12% vs 2024

€ 95,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,299

▲ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 36,661

▲ 19% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,645

▲ 83% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 161,290 Gross margin 2022: € 161,290 First fiscal year in the series	€ 177,512 Gross margin 2023: € 177,512 ▲ 10% vs 2022 (€ 161,290) Favourable step	€ 189,819 Gross margin 2024: € 189,819 ▲ 7% vs 2023 (€ 177,512) Favourable step	€ 215,257 Gross margin 2025: € 215,257 ▲ 13% vs 2024 (€ 189,819) Favourable step	▲ 13%
Profit after taxes	€ 34,759 Profit after taxes 2022: € 34,759 First fiscal year in the series	€ 49,100 Profit after taxes 2023: € 49,100 ▲ 41% vs 2022 (€ 34,759) Favourable step	€ 58,959 Profit after taxes 2024: € 58,959 ▲ 20% vs 2023 (€ 49,100) Favourable step	€ 67,165 Profit after taxes 2025: € 67,165 ▲ 14% vs 2024 (€ 58,959) Favourable step	▲ 14%
Equity	€ 266,133 Equity 2022: € 266,133 First fiscal year in the series	€ 165,234 Equity 2023: € 165,234 ▼ 38% vs 2022 (€ 266,133) Unfavourable step	€ 74,193 Equity 2024: € 74,193 ▼ 55% vs 2023 (€ 165,234) Unfavourable step	€ 68,200 Equity 2025: € 68,200 ▼ 8% vs 2024 (€ 74,193) Unfavourable step	▼ 8%
Total debts	€ 194,890 Total debts 2022: € 194,890 First fiscal year in the series	€ 366,914 Total debts 2023: € 366,914 ▲ 88% vs 2022 (€ 194,890) Unfavourable step	€ 496,282 Total debts 2024: € 496,282 ▲ 35% vs 2023 (€ 366,914) Unfavourable step	€ 587,439 Total debts 2025: € 587,439 ▲ 18% vs 2024 (€ 496,282) Unfavourable step	▲ 18%
Cash	€ 248,200 Cash 2022: € 248,200 First fiscal year in the series	€ 289,286 Cash 2023: € 289,286 ▲ 17% vs 2022 (€ 248,200) Favourable step	€ 323,762 Cash 2024: € 323,762 ▲ 12% vs 2023 (€ 289,286) Favourable step	€ 388,751 Cash 2025: € 388,751 ▲ 20% vs 2024 (€ 323,762) Favourable step	▲ 20%
Retained profit	€ 204,133 Retained profit 2022: € 204,133 First fiscal year in the series	€ 103,234 Retained profit 2023: € 103,234 ▼ 49% vs 2022 (€ 204,133) Unfavourable step	€ 12,193 Retained profit 2024: € 12,193 ▼ 88% vs 2023 (€ 103,234) Unfavourable step	€ 6,200 Retained profit 2025: € 6,200 ▼ 49% vs 2024 (€ 12,193) Unfavourable step	▼ 49%
Dividend	€ 150,000 Dividend 2022: € 150,000 First fiscal year in the series	€ 150,000 Dividend 2023: € 150,000 Unchanged (€ 150,000) Unchanged	€ 150,000 Dividend 2024: € 150,000 Unchanged (€ 150,000) Unchanged	€ 73,158 Dividend 2025: € 73,158 ▼ 51% vs 2024 (€ 150,000) Unchanged	▼ 51%
Balance sheet total	€ 461,023 Balance sheet total 2022: € 461,023 First fiscal year in the series	€ 532,148 Balance sheet total 2023: € 532,148 ▲ 15% vs 2022 (€ 461,023) Unchanged	€ 570,476 Balance sheet total 2024: € 570,476 ▲ 7% vs 2023 (€ 532,148) Unchanged	€ 655,639 Balance sheet total 2025: € 655,639 ▲ 15% vs 2024 (€ 570,476) Unchanged	▲ 15%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.6 Employees (FTE) 2023: 1.6 Unchanged (1.6) Unchanged	1.3 Employees (FTE) 2024: 1.3 ▼ 0.3 vs 2023 (1.6) Unchanged	1.3 Employees (FTE) 2025: 1.3 Unchanged (1.3) Unchanged

Key figures of APOTHEEK JANSSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK JANSSEN?

What happened at APOTHEEK JANSSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Leen De Coninck stepped down as director. NBB
2029 ARCOFAR stepped down as director. NBB
Jun 12, 2026 New annual accounts for financial year 2025: profit of € 67,165 (▲ 14% vs 2024). Source: NBB ↗
2023 Leen De Coninck became a director. NBB
2023 ARCOFAR became a director. NBB
Jan 1, 1984 New establishment in Deinze. KBO
Dec 31, 1983 Start of the company according to the CBE. KBO

In short

From € 34,759 profit in 2022 to € 67,165 profit in 2025.

Paid € 70,179 in corporate taxes since 2022.

Best year ever: 2025, with € 67,165 profit.

On average € 165,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ARCOFAR 100%

The stake of ARCOFAR comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK JANSSEN

The shares are held by ARCOFAR (100%).

Directors

According to the 2025 annual accounts

Leen De Coninck

Managing director

Also active at: ARCOFAR

since 2023 · until 2029

ARCOFAR

Managing director · represented by Geert Noë

since 2023 · until 2029

Shareholders

ARCOFAR

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Velostraat 48

9800 Deinze

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

NIPACO

€ 43,183 gross margin · 2025

ARCOFAR same network

€ 149,081 gross margin · 2025

GROEP ARCOFAR

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekdeinze.be

About

Technologies

ApacheGoogle FontsVarnish

Hosting & Email

Email provider

Self-hosted

Hosting

ONECOM, DK

Website info

HTTPS Ja

Languages NL

Features

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0425.202.369

VAT number

BE 0425.202.369

Registered office

Velostraat 48, 9800 Deinze

Names & denominations

APOTHEEK JANSSEN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

31 December 1983

Peppol

Active · Active since 21 Mar 2025

Contact

apotheekdeinze.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK JANSSEN

Financials

What happened to APOTHEEK JANSSEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions